跳至主導覽 跳至搜尋 跳過主要內容

Synergistic interaction of benign prostatic hyperplasia and prostatitis on prostate cancer risk

  • S. C. Hung
  • , S. W. Lai
  • , P. Y. Tsai
  • , P. C. Chen
  • , H. C. Wu
  • , W. H. Lin
  • , F. C. Sung*
  • *此作品的通信作者
  • Welfare Nantou Hospital
  • China Medical University Taichung

研究成果: 期刊稿件文章同行評審

44 引文 斯高帕斯(Scopus)

摘要

Background: The incidence of prostate cancer is much lower in Asian men than in Western men. This study investigated whether prostate cancer is associated with prostatitis, benign prostatic hyperplasia (BPH), and other medical conditions in the low-incidence population. Methods: From the claims data obtained from the universal National Health Insurance of Taiwan, we identified 1184 patients with prostate cancer diagnosed from 1997 to 2008. Controls comprised 4736 men randomly selected from a cancer-free population. Both groups were 50 years of age or above. Medical histories between the two groups were compared. Results: Multivariate logistic regression analysis showed that prostatitis and BPH had stronger association with prostate cancer than the other medical conditions tested. Compared with men without prostatitis and BPH, a higher odds ratio (OR) for prostate cancer was associated with BPH (26.2, 95% confidence interval (CI) 20.8-33.0) than with prostatitis (10.5, 95% CI=3.36-32.7). Men with both conditions had an OR of 49.2 (95% CI=34.7-69.9). Conclusion: Men with prostate cancer have strong association with prostatitis and/or BPH. Prostatitis interacts with BPH, resulting in higher estimated relative risk of prostate cancer in men suffering from both conditions.

原文英語
頁(從 - 到)1778-1783
頁數6
期刊British Journal of Cancer
108
發行號9
DOIs
出版狀態已出版 - 14 05 2013
對外發佈

UN SDG

此研究成果有助於以下永續發展目標

  1. SDG3 健康與福祉
    SDG3 健康與福祉

指紋

深入研究「Synergistic interaction of benign prostatic hyperplasia and prostatitis on prostate cancer risk」主題。共同形成了獨特的指紋。

引用此